<DOC>
	<DOCNO>NCT02686359</DOCNO>
	<brief_summary>If epidemiological study indicate relatively low prevalence report general population , idiopathic burn mouth syndrome ( BMS ) common condition among certain group population : 30 % menopausal woman experience oral burn vary degree . Despite significant progress make recent year , understand physiopathogeny , treatment option remain limited disappointing , result impairment quality life . Given chronic nature idiopathic burn mouth syndrome , need identify cause effective treatment modality subject suffer essential .</brief_summary>
	<brief_title>Opiorphin Levels Fluids Burning Mouth Syndrome Patients ( OPIODYN )</brief_title>
	<detailed_description>Idiopathic burn mouth syndrome ( BMS ) chronic orofacial pain condition pain felt intense , locate tongue oral mucosa know cause . The pain may last year present treatment little effect . BMS primarily feminine disease , affect woman follow menopause , suggest etiopathogenic role sexual hormone potentiate local salivary factor . An anxiodepressive component often associated disease . Recently , molecule name opiorphin identify human saliva . In animal , molecule show potent analgesic property comparable morphine . The hypothesis investigator molecule low quantity saliva person suffer BMS decrease cause oral burn sensation . The main objective study test hypothesis decrease opiorphin level saliva patient suffer primary BMS compare group control subject . The main judgment criterion level salivary opiorphin ng/mL . The propose study multicentric , simple blind case control study . The investigator collect data 21 primary BMS patient 21 control subject match sex , age , hormonal status ( menopause ) . The alpha risk 0.5 % power study 90 % . Criteria inclusion : BMS patient suffer 4 month burn pain tongue oral mucosa organic trouble detectable anamnesis , clinical evaluation biological testing . The design study include three session subject group ; maximum duration participation subject 8 week total duration study 24 month There two investigation center .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Burning Mouth Syndrome</mesh_term>
	<criteria>Clinical diagnosis Burning Mouth Syndrome Age 18 80 year Sensation pain oral mucosa , meet diagnostic criterion BMS ( Bergdahl Anneroth , 1993 , Scala 2003 ) Signature inform consent Healthy volunteer Age 18 80 year Patient age ( +/ 5 year ) , sex hormonal status ( menopause woman ) match Burning Mouth Syndrome patient Signature inform consent Dental periodontal pain month visit General pathology likely cause mouth pain ( diabetes , lupus , shingle , gastric reflux , allergy ... ) Chronic Orofacial pain Burning Mouth Syndrome Treatment molecule able induce oral burning sensation ( antiVEGF , neuroleptic , IEC angiotensin II ... ) Participation concomitantly biomedical research No affiliation social protection system Taste disorder dysgeusia link Burning Mouth Syndrome Inability understand information note sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>physiology</keyword>
	<keyword>pain</keyword>
	<keyword>analgesia</keyword>
	<keyword>saliva</keyword>
	<keyword>opiorphin</keyword>
</DOC>